Smartkarma Daily Briefs

Talk about timing… Friday before the close I wrote that I thought circumstances might merit a revised tilt at OZ Minerals Ltd (OZL AU) by BHP Group Ltd (BHP AU).
Earnings are Monday, copper is up in AUD terms, time is moving us forward into a supply squeeze. It all looks good to me.
But an article this morning in the AFR says BHP CEO Mike Henry called OZ Minerals “nice to have” not a “must have” and talked “discipline.” Oops.

Kotak Mahindra Bank (KMB IN): Foreign Room >20% Should See Staggered FTSE Inclusion Starting March

Foreign investor selling has taken the foreign headroom on Kotak Mahindra Bank (KMB) to 22%. That should result in the stock being added to the FTSE All-World Index in March.
The stock will initially be added to the index at an investability weight of 5%. Subject to >20% foreign headroom, the investability weight will increase by 5% at subsequent rebalances.
Continued foreign selling could result in an MSCI weight increase if the headroom increases above 25%. That could still be some time away though.

Last Week in Event SPACE: Toshiba, United Tractor, Recruit, Tyro Payments, DTAC/True, Bank Of Kyoto

Toshiba (6502 JP) investors should look at process and understand the difference between this one and others. Some news is not news, other than telling you the dance has started.
United Tractors (UNTR IJ) is cheap. It appears to be running at 6x 2022 earnings. This is not abnormal for a cyclical at the end of the cycle.
Westpac Banking (WBC AU) confirms its interest in Tyro Payments (TYR AU), but still nothing firm.

S&P/ASX Index Rebalance Preview: Moving the Right Way

We see one potential change for the S&P/ASX 50 Index and two potential changes for the S&P/ASX 200 at the December rebalance, though some stocks are close to the cutoffs.
The potential passive buying on the S&P/ASX 200 (AS51 INDEX) adds will exceed 11 days of ADV while the impact on the other stocks ranges from 1.5-4 days of ADV.
Most stocks have been moving the right way and there will be pre-positions built up on some of the stocks. Shorts have been active on a few names too.

Japan Excellent (8987) Has Been Most Excellent. It Should Still Be.

Two months ago I wrote about a possible “Sustained Flow Event” on Japan Excellent (8987 JP). Since then, the stock has outperformed every other Office REIT. It’s up since then.
Outperformance within Office REITs has been a minimum of 5.9%, and a maximum of ~17% vs the biggest peer, with an average and median outperformance of 10.8% and 9.2% respectively.
There is no reason to think it won’t continue, but the Japan Excellent story is idiosyncratic.

Socionext (6526) TOPIX Inclusion

System-On-Chip designer and IP purveyor Socionext (6526 JP) is a recent IPO in Japan, born from a spinout of Fujitsu and Panasonic system LSI operations 7+ years ago.
Having listed on TSE Prime from the outset, that means it gets TOPIX inclusion at the close of trading 29 November.
Inclusion Float is a bit nebulous. There is a chance we get official company data prior to the TSE announcement, in which case we know more by cob 31 October.

Index Rebalance & ETF Flow Recap: SZSE1000, NIFTY, HDFC/HDFCB, Ming Yuan, Blibli, KMB IN

The review period for the MSCI November SAIR started during the week and will run till 31 October. The TPX INDEX October rebalance will be implemented close on 28 October.
The HDFC/ HDFCB merger is progressing faster than expected. NSE Indices has started a market consultation on treatment of mergers and demergers in their indices.
There have been big redemptions in iShares MSCI Emerging Markets (EEM US) and iShares Core MSCI Emerging Markets ETF (IEMG US) during the week. Tracker Fund had big inflows.

Renesas (6723) | Bullish Toyota Troubles

By Mark Chadwick

We remain bullish on the stock price ahead of Q3 earnings
We expect the company to surprise the market given stronger volumes and pricing trends
If Toyota is having problems securing a stable supply of chips, we believe that industry inventories are much leaner than most believe

Giant Biogene IPO: Valuation First Look

By Arun George

Giant Biogene Holding (GBH HK), a leading professional skin care product manufacturer, is set to launch a US$500 million HKEx IPO.
We previously discussed the IPO in Giant Biogene IPO: The Bull Case and Giant Biogene IPO: The Bear Case.
In this note, we present our forecasts and take the first look at Giant Biogene’s potential valuation range.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief Australia: OZ Minerals Ltd, Nearmap Ltd, PolyNovo Ltd and more

By Smartkarma Daily Briefs | Australia, Daily Briefs

In today’s briefing:

OZ Minerals – Circumstances Apparently Do NOT Merit a Revised Tilt
Nearmap’s Spread Widens, Scheme Meeting on 25 November
Nearmap (NEA AU): 25 Nov Scheme Meeting. IE Says Fair & Reasonable
PolyNovo Ltd (PNV AU): Shares Are Rallying Fueled by Strong US Sales and New Product Approval

OZ Minerals – Circumstances Apparently Do NOT Merit a Revised Tilt

Talk about timing… Friday before the close I wrote that I thought circumstances might merit a revised tilt at OZ Minerals Ltd (OZL AU) by BHP Group Ltd (BHP AU).
Earnings are Monday, copper is up in AUD terms, time is moving us forward into a supply squeeze. It all looks good to me.
But an article this morning in the AFR says BHP CEO Mike Henry called OZ Minerals “nice to have” not a “must have” and talked “discipline.” Oops.

Nearmap’s Spread Widens, Scheme Meeting on 25 November

By Arun George

The IE considers Thoma Bravo’s A$2.10 offer fair and reasonable as it is within its valuation range of A$1.94 to A$2.45 per share (but the below the midpoint of A$2.20).
The spread has risen due to suggestions that some investors aim to block the scheme. These investors aim for a bump but will likely settle for the offer if unsuccessful.
At Nearmap Ltd (NEA AU)‘s last close price and for the 15 December payment, the gross and annualised spread is 5.8% and 44.5%, respectively.

Nearmap (NEA AU): 25 Nov Scheme Meeting. IE Says Fair & Reasonable

On the 15 August, mapping technology outfit Nearmap Ltd (NEA AU) unanimously backed Thoma Bravo’s A$2.10/share Offer by way of a Scheme of Arrangement.
The Scheme Booklet has now been lodged with ASIC. The Independent Expert reckons the Offer is fair and reasonable.
The Scheme Meeting will be held on the 25 November, as previously flagged in August’s SID, with an expected implementation on the 15 December.

PolyNovo Ltd (PNV AU): Shares Are Rallying Fueled by Strong US Sales and New Product Approval

By Tina Banerjee

PolyNovo Ltd (PNV AU) reported 73% y/y revenue growth to A$12.5M in Q1FY23, driven by the U.S. The company reported record high monthly sales of A$5.4M in September 2022.
The company is aggressively expanding team and the increased headcount is having the desired impact on sales growth and loss continues to be minimized compared to business expansion.
PolyNovo received FDA clearance for NovoSorb MTX, which expands PolyNovo’s U.S. addressable market by ~A$500M. The company plans to launch SynPath in the U.S. in 2023 (addressable market ~$400M).

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief Indonesia: Ciputra Development and more

By Smartkarma Daily Briefs | Daily Briefs, Indonesia

In today’s briefing:

Ciputra Development (CTRA IJ) – The Cosmopolitan Developer

Ciputra Development (CTRA IJ) – The Cosmopolitan Developer

By Angus Mackintosh

Ciputra Development (CTRA IJ) is Indonesia’s most geographically diversified and land bank-rich property developers, and also the pioneer of joint operating schemes that have allowed for faster expansion.
The company reported a solid set of 1H2022 results with strong 9M2022 marketing sales pointing towards higher growth ahead, with guidance already revised upwards.
Ciputra Development is a core proxy for the ongoing residential market recovery in Indonesia and valuations are significantly below the 5-year average on both PBV and PER.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief United States: iShares MSCI Emerging Markets, Carnival Corp, Akamai Technologies, Philip Morris International, Phillips 66, Sirius Xm Holdings, Walgreens Boots Alliance, Zoominfo Technologies, Bitcoin, Carmax Inc and more

By Smartkarma Daily Briefs | Daily Briefs, United States

In today’s briefing:

Index Rebalance & ETF Flow Recap: SZSE1000, NIFTY, HDFC/HDFCB, Ming Yuan, Blibli, KMB IN
Carnival Corp: New Cruise Ship Additions & Other Drivers
Akamai Technologies: Malware Protection For APIs and Apps
Philip Morris International: Expansion In The Philippines
Phillips 66: Potential Acquisition of DCP Midstream & Other Drivers
Sirius XM Holding: Project Amplify Update & Key Drivers
Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers
ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers
Quant Network
CarMax Inc: Major Drivers

Index Rebalance & ETF Flow Recap: SZSE1000, NIFTY, HDFC/HDFCB, Ming Yuan, Blibli, KMB IN

The review period for the MSCI November SAIR started during the week and will run till 31 October. The TPX INDEX October rebalance will be implemented close on 28 October.
The HDFC/ HDFCB merger is progressing faster than expected. NSE Indices has started a market consultation on treatment of mergers and demergers in their indices.
There have been big redemptions in iShares MSCI Emerging Markets (EEM US) and iShares Core MSCI Emerging Markets ETF (IEMG US) during the week. Tracker Fund had big inflows.

Carnival Corp: New Cruise Ship Additions & Other Drivers

Carnival Corp has continued its string of disappointing results and the company failed to meet Wall Street expectations in terms of revenues as well as earnings in the last quarter as well.
Given the resumption of the guest cruise operations, the company saw its adjusted EBITDA being positive for the first time.
The revenue of the last quarter increased by around 80% in comparison to the previous quarter.

Akamai Technologies: Malware Protection For APIs and Apps

After a steady correction over the past few months, Akamai’s stock has been appreciating steadily with its results being a few days away.
Akamai has been leveraging its financial strength to make substantial investments in cloud computing and financial strength.
The company’s security portfolio of zero trust enterprise has been performing well with several significant customer wins.

Philip Morris International: Expansion In The Philippines

Philip Morris continued to demonstrate a strong underlying momentum with positive volume that supported a better than expected top-line growth in the last quarter.
The company delivered yet another all-around beat as net revenues of pro forma grew organically, which reflects continued strong growth in IQOS as well as the ongoing recovery of combustible business in various markets.
Strong quarter pro forma user growth and continued excellent IQOS performance were very impressive.

Phillips 66: Potential Acquisition of DCP Midstream & Other Drivers

With the results of Phillips 66 around the corner, the stock price has been appreciating over the past few weeks.
Among major updates, Phillips 66 has offered to acquire the public units of DCP Midstream, the natural gas company, to boost its business of natural gas liquids.
We provide the stock of Phillips 66 a ‘Hold’ rating and a revision in the target price.

Sirius XM Holding: Project Amplify Update & Key Drivers

Sirius XM has had a volatile trajectory off late in terms of its stock price performance and with its results around the corner, another key factor that must be remembered is its history of below par earnings.
The company is making progress in deploying its 360L platform, and it is making progress with various EV start-ups.
We provide the stock of Sirius with a ‘Hold’ rating with a revision in the target price.

Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers

Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result.
In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts.
We provide the stock of Walgreens with a ‘Hold’ rating and a revision in the target price.dditional workstreams for its consumer-facing digital assistant.

ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers

With its next set of results around the corner, ZoomInfo Technologies definitely has a lot to look forward to.
The company’s stock has remained stable in an otherwise bearish environment for the technology industry.
We provide the stock of ZoomInfo with a ‘Buy’ rating with a revision in the target price.

Quant Network

By Etherbridge

Over the last few weeks, we have covered the topic of interoperability, and the different approaches projects have taken to solve the problem.
The first approach was on-chain with Polkadot and Cosmos, and last week, we covered how open-source projects like Chainlink are doing it without a blockchain.
This week we will cover the Quant Network, a closed-source project that focuses on creating interoperability between enterprise chains, governments, regulatory bodies and specific open blockchains.

CarMax Inc: Major Drivers

CarMax’s stock has been on a downward trajectory since the last quarterly result which had been a major disappointment.
In response to consumer demand and the current environment, CarMax continued to offer a higher mix of lower-priced vehicles.
We provide the stock of CarMax a ‘Hold’ rating with a revision in the target price.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief China: Semiconductor Manufacturing International Corp (SMIC), C C Land Holdings, Giant Biogene Holding and more

By Smartkarma Daily Briefs | China, Daily Briefs

In today’s briefing:

FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?
Hong Kong CEO & Director Dealings: 21st Oct: Impro Precision, Wealthking, C C Land, China Bright
ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate

FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?

By Douglas Kim

In the past couple of weeks, there have been tremendous sanctions by the US government on China’s semiconductor sector.
In this insight, we compare this move to the US government putting a trade embargo on oil against Japan nearly 81 years ago.
If there are severe disruptions to the semiconductor market in China, this will likely to have negative impact on the two Korean semi giants Samsung Electronics and SK Hynix.

Hong Kong CEO & Director Dealings: 21st Oct: Impro Precision, Wealthking, C C Land, China Bright

The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. However, such disclosures are by no means an absolute.
These insights may flag those companies where shares have been pledged. Stocks mentioned include Impro (1286 HK), Wealthking (1140 HK), C C Land (1224 HK), and China Bright (1859 HK).

ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate

By Sumeet Singh

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
On the IPO front, Blibli launched its Indonesian IPO, while a few other names are said to be gearing up to launch in Hong Kong and India.
There were a few placements this week, notable ones being Mitsubishi Estate Logistics (3481 JP) and Zee Entertainment Enterprises (Z IN).

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief Japan: Japan Excellent, Toshiba Corp, Shinsei Bank, Tokyo Stock Exchange Tokyo Price Index Topix and more

By Smartkarma Daily Briefs | Daily Briefs, Japan

In today’s briefing:

Japan Excellent (8987) Has Been Most Excellent. It Should Still Be.
Last Week in Event SPACE: Toshiba, United Tractor, Recruit, Tyro Payments, DTAC/True, Bank Of Kyoto
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Tyro, Fengxiang, Singapore Medical, Shinsei Bank, True/DTAC
Prime Market Should Raise Market Cap Standards. Companies Should Take Measures to Raise Valuations

Japan Excellent (8987) Has Been Most Excellent. It Should Still Be.

Two months ago I wrote about a possible “Sustained Flow Event” on Japan Excellent (8987 JP). Since then, the stock has outperformed every other Office REIT. It’s up since then.
Outperformance within Office REITs has been a minimum of 5.9%, and a maximum of ~17% vs the biggest peer, with an average and median outperformance of 10.8% and 9.2% respectively.
There is no reason to think it won’t continue, but the Japan Excellent story is idiosyncratic.

Last Week in Event SPACE: Toshiba, United Tractor, Recruit, Tyro Payments, DTAC/True, Bank Of Kyoto

Toshiba (6502 JP) investors should look at process and understand the difference between this one and others. Some news is not news, other than telling you the dance has started.
United Tractors (UNTR IJ) is cheap. It appears to be running at 6x 2022 earnings. This is not abnormal for a cyclical at the end of the cycle.
Westpac Banking (WBC AU) confirms its interest in Tyro Payments (TYR AU), but still nothing firm.

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Tyro, Fengxiang, Singapore Medical, Shinsei Bank, True/DTAC

There are 45 – mostly firm, mostly Asia-Pac – transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.
I see no new deals discussed on Smartkarma this week.
Key updates took place for Tyro (TYR AU), Shandong Fengxiang (9977 HK), Singapore Medical (SMG SP), Shinsei Bank (8303 JP), and True (TRUE TB) / Total Access Communication (DTAC TB).

Prime Market Should Raise Market Cap Standards. Companies Should Take Measures to Raise Valuations

By Aki Matsumoto

There is a discrepancy between the prime market concept and the listing criteria of 10 billion yen in tradable market capitalization.
The most significant effect of the market restructuring was the elimination of parent-subsidiary listings, but companies are reluctant to discuss matters not explicitly addressed in the corporate governance code.
Increasing market capitalization is not an overnight solution, but companies should study the initiatives advanced by companies that have increased valuations and implement those initiatives.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief Consumer: Carnival Corp, Carmax Inc, Philip Morris International, Sirius Xm Holdings, Walgreens Boots Alliance and more

By Smartkarma Daily Briefs | Consumer, Daily Briefs

In today’s briefing:

Carnival Corp: New Cruise Ship Additions & Other Drivers
CarMax Inc: Major Drivers
Philip Morris International: Expansion In The Philippines
Sirius XM Holding: Project Amplify Update & Key Drivers
Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers

Carnival Corp: New Cruise Ship Additions & Other Drivers

Carnival Corp has continued its string of disappointing results and the company failed to meet Wall Street expectations in terms of revenues as well as earnings in the last quarter as well.
Given the resumption of the guest cruise operations, the company saw its adjusted EBITDA being positive for the first time.
The revenue of the last quarter increased by around 80% in comparison to the previous quarter.

CarMax Inc: Major Drivers

CarMax’s stock has been on a downward trajectory since the last quarterly result which had been a major disappointment.
In response to consumer demand and the current environment, CarMax continued to offer a higher mix of lower-priced vehicles.
We provide the stock of CarMax a ‘Hold’ rating with a revision in the target price.

Philip Morris International: Expansion In The Philippines

Philip Morris continued to demonstrate a strong underlying momentum with positive volume that supported a better than expected top-line growth in the last quarter.
The company delivered yet another all-around beat as net revenues of pro forma grew organically, which reflects continued strong growth in IQOS as well as the ongoing recovery of combustible business in various markets.
Strong quarter pro forma user growth and continued excellent IQOS performance were very impressive.

Sirius XM Holding: Project Amplify Update & Key Drivers

Sirius XM has had a volatile trajectory off late in terms of its stock price performance and with its results around the corner, another key factor that must be remembered is its history of below par earnings.
The company is making progress in deploying its 360L platform, and it is making progress with various EV start-ups.
We provide the stock of Sirius with a ‘Hold’ rating with a revision in the target price.

Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers

Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result.
In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts.
We provide the stock of Walgreens with a ‘Hold’ rating and a revision in the target price.dditional workstreams for its consumer-facing digital assistant.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief Health Care: Giant Biogene Holding, PolyNovo Ltd, Tokyo Stock Exchange Tokyo Price Index Topix and more

By Smartkarma Daily Briefs | Daily Briefs, Healthcare

In today’s briefing:

ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate
PolyNovo Ltd (PNV AU): Shares Are Rallying Fueled by Strong US Sales and New Product Approval
Prime Market Should Raise Market Cap Standards. Companies Should Take Measures to Raise Valuations

ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate

By Sumeet Singh

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
On the IPO front, Blibli launched its Indonesian IPO, while a few other names are said to be gearing up to launch in Hong Kong and India.
There were a few placements this week, notable ones being Mitsubishi Estate Logistics (3481 JP) and Zee Entertainment Enterprises (Z IN).

PolyNovo Ltd (PNV AU): Shares Are Rallying Fueled by Strong US Sales and New Product Approval

By Tina Banerjee

PolyNovo Ltd (PNV AU) reported 73% y/y revenue growth to A$12.5M in Q1FY23, driven by the U.S. The company reported record high monthly sales of A$5.4M in September 2022.
The company is aggressively expanding team and the increased headcount is having the desired impact on sales growth and loss continues to be minimized compared to business expansion.
PolyNovo received FDA clearance for NovoSorb MTX, which expands PolyNovo’s U.S. addressable market by ~A$500M. The company plans to launch SynPath in the U.S. in 2023 (addressable market ~$400M).

Prime Market Should Raise Market Cap Standards. Companies Should Take Measures to Raise Valuations

By Aki Matsumoto

There is a discrepancy between the prime market concept and the listing criteria of 10 billion yen in tradable market capitalization.
The most significant effect of the market restructuring was the elimination of parent-subsidiary listings, but companies are reluctant to discuss matters not explicitly addressed in the corporate governance code.
Increasing market capitalization is not an overnight solution, but companies should study the initiatives advanced by companies that have increased valuations and implement those initiatives.

💡 Before it’s here, it’s on Smartkarma

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

✓ Unlimited Research Summaries
✓ Personalised Alerts
✓ Custom Watchlists
✓ Company Data and News
✓ Events & Webinars

Oct 23

Daily Brief TMT/Internet: iShares MSCI Emerging Markets, Nearmap Ltd, Semiconductor Manufacturing International Corp (SMIC), Akamai Technologies, Accenture Plc Cl A, Zoominfo Technologies and more

By Smartkarma Daily Briefs | Daily Briefs, TMT/Internet

In today’s briefing:

Index Rebalance & ETF Flow Recap: SZSE1000, NIFTY, HDFC/HDFCB, Ming Yuan, Blibli, KMB IN
Nearmap’s Spread Widens, Scheme Meeting on 25 November
Nearmap (NEA AU): 25 Nov Scheme Meeting. IE Says Fair & Reasonable
FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?
Akamai Technologies: Malware Protection For APIs and Apps
Accenture plc: Acquisition of MacGregor Partners & Other Drivers
ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers

Index Rebalance & ETF Flow Recap: SZSE1000, NIFTY, HDFC/HDFCB, Ming Yuan, Blibli, KMB IN

The review period for the MSCI November SAIR started during the week and will run till 31 October. The TPX INDEX October rebalance will be implemented close on 28 October.
The HDFC/ HDFCB merger is progressing faster than expected. NSE Indices has started a market consultation on treatment of mergers and demergers in their indices.
There have been big redemptions in iShares MSCI Emerging Markets (EEM US) and iShares Core MSCI Emerging Markets ETF (IEMG US) during the week. Tracker Fund had big inflows.

Nearmap’s Spread Widens, Scheme Meeting on 25 November

By Arun George

The IE considers Thoma Bravo’s A$2.10 offer fair and reasonable as it is within its valuation range of A$1.94 to A$2.45 per share (but the below the midpoint of A$2.20).
The spread has risen due to suggestions that some investors aim to block the scheme. These investors aim for a bump but will likely settle for the offer if unsuccessful.
At Nearmap Ltd (NEA AU)‘s last close price and for the 15 December payment, the gross and annualised spread is 5.8% and 44.5%, respectively.

Nearmap (NEA AU): 25 Nov Scheme Meeting. IE Says Fair & Reasonable

On the 15 August, mapping technology outfit Nearmap Ltd (NEA AU) unanimously backed Thoma Bravo’s A$2.10/share Offer by way of a Scheme of Arrangement.
The Scheme Booklet has now been lodged with ASIC. The Independent Expert reckons the Offer is fair and reasonable.
The Scheme Meeting will be held on the 25 November, as previously flagged in August’s SID, with an expected implementation on the 15 December.

FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?

By Douglas Kim

In the past couple of weeks, there have been tremendous sanctions by the US government on China’s semiconductor sector.
In this insight, we compare this move to the US government putting a trade embargo on oil against Japan nearly 81 years ago.
If there are severe disruptions to the semiconductor market in China, this will likely to have negative impact on the two Korean semi giants Samsung Electronics and SK Hynix.

Akamai Technologies: Malware Protection For APIs and Apps

After a steady correction over the past few months, Akamai’s stock has been appreciating steadily with its results being a few days away.
Akamai has been leveraging its financial strength to make substantial investments in cloud computing and financial strength.
The company’s security portfolio of zero trust enterprise has been performing well with several significant customer wins.

Accenture plc: Acquisition of MacGregor Partners & Other Drivers

Accenture delivered a good performance in its last result surpassing Wall Street expectations in terms of revenues as well as earnings.
The company’s revenues grew in local currency which was driven by double-digit growth across all industries, services, and markets.
The cloud business of Accenture performed well, with Cloud First being one of the big drivers of growth.

ZoomInfo Technologies Inc: ZoomInfo Labs Launch & Other Drivers